Market Access
Capital discipline in biotech: Building enduring companies w...
Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.
News
Jazz and Lilly cancer drugs cleared for use by NHS
Jazz's biliary tract cancer drug Ziihera and Lilly's Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance.
News
FDA kicks off review of Roche's Gazyva for wider lupus use
Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus erythematosus.
News
Trump signs order to hasten psychedelic medicine access
Donald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of bringing psychedelics to patients.
News
Multiple myeloma drug Blenrep backed for wider NHS use
The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple myeloma drug more widely.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
